Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Robert J. Smeenk"'
Autor:
Niven Mehra, Iris Kloots, Michiel Vlaming, Shafak Aluwini, Els Dewulf, Daniela E. Oprea-Lager, Henk van der Poel, Herman Stoevelaar, Derya Yakar, Chris H. Bangma, Elise Bekers, Roderick van den Bergh, Andries M. Bergman, Franchette van den Berkmortel, Steve Boudewijns, Winand N.M. Dinjens, Jurgen Fütterer, Tom van der Hulle, Guido Jenster, Leonie I. Kroeze, Michel van Kruchten, Geert van Leenders, Pim J. van Leeuwen, Wendy W.J. de Leng, R. Jeroen A. van Moorselaar, Walter Noordzij, Rogier A. Oldenburg, Inge M. van Oort, Irma Oving, Jack A. Schalken, Ivo G. Schoots, Ed Schuuring, Robert J. Smeenk, Ben G.L. Vanneste, Erik Vegt, André N. Vis, Kim de Vries, Peter-Paul M. Willemse, Maurits Wondergem, Margreet Ausems
Publikováno v:
European Urology Open Science, Vol 49, Iss , Pp 23-31 (2023)
Background: Germline and tumour genetic testing in prostate cancer (PCa) is becoming more broadly accepted, but testing indications and clinical consequences for carriers in each disease stage are not yet well defined. Objective: To determine the con
Externí odkaz:
https://doaj.org/article/6f52ae4fdd99475585e6ab93b18449bb
Autor:
Rik van den Elshout, Tom W. J. Scheenen, Chantal M. L. Driessen, Robert J. Smeenk, Frederick J. A. Meijer, Dylan Henssen
Publikováno v:
Insights into Imaging, Vol 13, Iss 1, Pp 1-12 (2022)
Abstract Background In a considerable subgroup of glioma patients treated with (chemo) radiation new lesions develop either representing tumor progression (TP) or treatment-related abnormalities (TRA). Quantitative diffusion imaging metrics such as t
Externí odkaz:
https://doaj.org/article/543d49da118e4ca49969e42643b81e5e
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 29, Iss , Pp 40-46 (2021)
Background and purpose: For irradiation of localized prostate-cancer, moderately-hypofractionated regimens with a variety of dose per fraction are used. We adopted a regimen of 70 Gy in 28 fractions of 2.5 Gy, using state of the art radiotherapy (RT)
Externí odkaz:
https://doaj.org/article/c7b4c093594b4e7bbace757fcddd30cc
Autor:
Marie-Christina Jahreiß, Wilma D. Heemsbergen, Bo van Santvoort, Mischa Hoogeman, Maarten Dirkx, Floris J. Pos, Tomas Janssen, Andre Dekker, Ben Vanneste, Andre Minken, Carel Hoekstra, Robert J. Smeenk, Inge M. van Oort, Chris H. Bangma, Luca Incrocci, Katja K. H. Aben
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeExternal Beam Radiotherapy (EBRT) techniques dramatically changed over the years. This may have affected the risk of radiation-induced second primary cancers (SPC), due to increased irradiated low dose volumes and scatter radiation. We investi
Externí odkaz:
https://doaj.org/article/e94401e37f50411fad083642701633c0
Autor:
James Nagarajah, J. Alfred Witjes, Martin Gotthardt, Jelle O. Barentsz, Sandra Heskamp, Jean-Paul A. van Basten, Diederik M. Somford, Robert J. Smeenk, Linda G.W. Kerkmeijer, Niven Mehra, Winald R. Gerritsen, J. Fred Verzijlbergen, Tom W.J. Scheenen, Annemarie Eek, Melline G.M. Schilham, Maike J.M. Uijen, Patrik Zámecnik, Mark W. Konijnenberg, J.P. Michiel Sedelaar, Marcel J.R. Janssen, Inge M. van Oort, Constantijn H.J. Muselaers, Steffie M.B. Peters, Bastiaan M. Privé
Purpose:[177Lu]Lu-PSMA-617 radioligand therapy (177Lu-PSMA) is a novel treatment for metastatic castration-resistant prostate cancer (mCRPC), which could also be applied to patients with metastatic hormone-sensitive prostate cancer (mHSPC) with PSMA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee5227f2482c2e8c0f3bed1c1ab3d53
https://doi.org/10.1158/1078-0432.c.6530696.v1
https://doi.org/10.1158/1078-0432.c.6530696.v1
Autor:
James Nagarajah, J. Alfred Witjes, Martin Gotthardt, Jelle O. Barentsz, Sandra Heskamp, Jean-Paul A. van Basten, Diederik M. Somford, Robert J. Smeenk, Linda G.W. Kerkmeijer, Niven Mehra, Winald R. Gerritsen, J. Fred Verzijlbergen, Tom W.J. Scheenen, Annemarie Eek, Melline G.M. Schilham, Maike J.M. Uijen, Patrik Zámecnik, Mark W. Konijnenberg, J.P. Michiel Sedelaar, Marcel J.R. Janssen, Inge M. van Oort, Constantijn H.J. Muselaers, Steffie M.B. Peters, Bastiaan M. Privé
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5752047a06c3325540f120e571753c90
https://doi.org/10.1158/1078-0432.22481447
https://doi.org/10.1158/1078-0432.22481447
Autor:
Dylan Henssen, Lars Leijten, Frederick J. A. Meijer, Anja van der Kolk, Anne I. J. Arens, Mark ter Laan, Robert J. Smeenk, Anja Gijtenbeek, Elsmarieke M. van de Giessen, Nelleke Tolboom, Daniela E. Oprea-Lager, Marion Smits, James Nagarajah
Publikováno v:
Cancers, 15, 9
Cancers, 15
Henssen, D, Leijten, L, Meijer, F J A, van der Kolk, A, Arens, A I J, ter Laan, M, Smeenk, R J, Gijtenbeek, A, van de Giessen, E M, Tolboom, N, Oprea-Lager, D E, Smits, M & Nagarajah, J 2023, ' Head-To-Head Comparison of PET and Perfusion Weighted MRI Techniques to Distinguish Treatment Related Abnormalities from Tumor Progression in Glioma ', Cancers, vol. 15, no. 9, 2631 . https://doi.org/10.3390/cancers15092631
Cancers, 15
Henssen, D, Leijten, L, Meijer, F J A, van der Kolk, A, Arens, A I J, ter Laan, M, Smeenk, R J, Gijtenbeek, A, van de Giessen, E M, Tolboom, N, Oprea-Lager, D E, Smits, M & Nagarajah, J 2023, ' Head-To-Head Comparison of PET and Perfusion Weighted MRI Techniques to Distinguish Treatment Related Abnormalities from Tumor Progression in Glioma ', Cancers, vol. 15, no. 9, 2631 . https://doi.org/10.3390/cancers15092631
Contains fulltext : 292741.pdf (Publisher’s version ) (Open Access) The post-treatment imaging surveillance of gliomas is challenged by distinguishing tumor progression (TP) from treatment-related abnormalities (TRA). Sophisticated imaging techniqu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfd14887546ffed2c2d169421f20041f
https://doi.org/10.3390/cancers15092631
https://doi.org/10.3390/cancers15092631
Autor:
Lisa De Cock, Cédric Draulans, Floris J. Pos, Sofie Isebaert, Robin De Roover, Uulke A. van der Heide, Robert J. Smeenk, Martina Kunze-Busch, Jochem van der Voort van Zyp, Hans de Boer, Linda G.W. Kerkmeijer, Karin Haustermans
Publikováno v:
Radiotherapy and Oncology. :109713
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5de3cf639b1cddd33654eb1e89bb16b5
https://doi.org/10.1016/j.radonc.2023.109713
https://doi.org/10.1016/j.radonc.2023.109713
Autor:
Veerle H. Groen, Karin Haustermans, Floris J. Pos, Cédric Draulans, Sofie Isebaert, Evelyn M. Monninkhof, Robert J. Smeenk, Martina Kunze-Busch, Johannes C.J. de Boer, Jochem van der Voort van Zijp, Linda G.W. Kerkmeijer, Uulke A. van der Heide
Publikováno v:
European Urology, 82, 252-257
European Urology, 82, 3, pp. 252-257
European Urology, 82, 3, pp. 252-257
Contains fulltext : 283434.pdf (Publisher’s version ) (Closed access) BACKGROUND: Focal dose escalation in external beam radiotherapy (EBRT) showed an increase in 5-yr biochemical disease-free survival in the Focal Lesion Ablative Microboost in Pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fea952fecc41631c2577f4732f4ec51
https://pubmed.ncbi.nlm.nih.gov/35579679
https://pubmed.ncbi.nlm.nih.gov/35579679
Autor:
Cédric, Draulans, Robin, De Roover, Uulke A, van der Heide, Linda, Kerkmeijer, Robert J, Smeenk, Floris, Pos, Wouter V, Vogel, James, Nagarajah, Marcel, Janssen, Sofie, Isebaert, Frederik, Maes, Cindy, Mai, Raymond, Oyen, Steven, Joniau, Martina, Kunze-Busch, Karolien, Goffin, Karin, Haustermans
Publikováno v:
European journal of nuclear medicine and molecular imaging. 48(4)
This study proposes optimal tracer-specific threshold-based window levels for PSMA PET-based intraprostatic gross tumour volume (GTV) contouring to reduce interobserver delineation variability.NineROC curve analysis forThreshold-based contouring usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d9487e9d5a419313d9d799503f4df0b7
https://pubmed.ncbi.nlm.nih.gov/33025093
https://pubmed.ncbi.nlm.nih.gov/33025093